IL1A and alkaline phosphatase measurement: The development of AP lesions is marked by an increase in inflammatory mediators, including IL-1⍺ expression that is found increased in both animal models [45] and human tissues [46], and that bone resorption is significantly blocked by infusion with neutralizing antibodies against IL-1⍺, confirming its pivotal role in mediating bone resorption in this disease [45].